Allstate Corporation’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Allstate Corporation’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,789	Closed	-$259K	–	752
2021 Q1	$259K	Buy	+3,789	New	+$306K	0.01%	680
2020 Q4	–	Sell	-3,430	Closed	-$223K	–	729
2020 Q3	$223K	Sell	3,430 -7	-0.2%	-$459	0.01%	632
2020 Q2	$251K	Buy	+3,437	New	+$183K	0.01%	623

Other funds holding BHVN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Allstate Corporation's BHVN Position: Q2 2021 in Review

Allstate Corporation sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q2 2021, closing a stake of 3,789 shares — an estimated $259K sold.

Allstate Corporation first reported a position in BHVN in Q2 2020 and held it in 3 quarters. The position peaked at $259K in Q1 2021. 223 funds tracked by Wall St. Rank hold BHVN as of Q2 2021.

Allstate Corporation reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q2 2021 after selling out during the quarter.
Allstate Corporation sold 3,789 Biohaven Pharmaceutical Holding Company Ltd. shares in Q2 2021, an estimated $259K.
Allstate Corporation first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2020 and held it in 3 quarters.
Allstate Corporation's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $259K in Q1 2021.
223 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q2 2021.

Based on Allstate Corporation's 13F filing for Q2 2021, filed 16 Aug 2021.